Author:
Ganesh S,Gonzalez-Edick M,Gibbons D,Ge Y,VanRoey M,Robinson M,Jooss K
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference26 articles.
1. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993; 53: 4477–4480.
2. Khuri FR, Jain SR . Novel agents and incremental advances in the treatment of head and neck cancer. Semin Oncol 2004; 31: 3–10.
3. Yoo GH, Piechocki MP, Oliver J, Lonardo F, Zumstein L, Lin HS et al. Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer. Laryngoscope 2004; 114: 1871–1879.
4. Post DE, Khuri FR, Simons JW, Van Meir EG . Replicative oncolytic adenoviruses in multimodal cancer regimens. Hum Gene Ther 2003; 14: 933–946.
5. Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 2000; 6: 879–885.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献